drugset / Trial / NCT02291926
Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect
Phase 1
Completed
20 enrolled
Shenzhen Hornetcorn Bio-technology Company, LTD
Fifth Affiliated Hospital of Guangzhou Medical University · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cell(hUC-MSC) for articular cartilage defect of knee.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-07
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 2e+07 cells | Other |